Document Detail


Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors.
MedLine Citation:
PMID:  23135377     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Homocysteine (Hcy) is metabolized through two pathways, requiring folates and B6-12 vitamins as cofactors. Increased Hcy concentration is responsible for early atherosclerosis with possible acute cardiovascular events. Ample evidence has demonstrated that Hcy lowering with folic acid and B vitamin supplementation, even if reduces Hcy serum levels, is unable to lower cardiovascular risk. On the contrary, omega-3 fatty acids and some nutraceuticals, such as N-acetyl cysteine, taurine, or S-adenosyl-methionine, reduce both Hcy serum concentration and cardiovascular risk. Instead, antiplatelet drugs, such as aspirin and clopidogrel or ticlopidine and statins only antagonize vascular derangements. Finally, metformin, some lipid-lowering drugs, and some diuretics should be avoided because they can increase Hcy levels.
Authors:
Federico Cacciapuoti
Related Documents :
1915877 - The retarded rate of acid-catalyzed solvolysis of glycoside bonds between reducing-end ...
334537 - Somatic antigens of shigella. the strucuture of the specific polysaccharide chain of sh...
17345317 - Structural characterization of anti-complementary polysaccharides from the leaves of ar...
8938377 - Structural study of a highly o-acetylated core of legionella pneumophila serogroup 1 li...
7104337 - Comparative lipid analysis of purified plasma membranes and shed extracellular membrane...
18967077 - Extraction of lead(ii) with cyanex 302 and its spectrophotometric determination with par.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  23     ISSN:  1473-5733     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  England    
Other Details:
Languages:  eng     Pagination:  677-9     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Second University of Naples, Naples, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cognition and Motor Impairment Correlates with Exercise Test Performance after Stroke.
Next Document:  Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?